1,25-Dihydroxyvitamin D3 enhances degranulation of mast cells

Molecular and Cellular Endocrinology

Volumn 142, Issue 1-2, 1998, Pages 49-55

  Shalita Chesner, M ^a   Koren, R ^a   Mekori, Y A ^a   Baram, D ^a   Rotem, C ^a   Liberman, U A ^a   Ravid, A ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Calcitriol; Exocytosis; Mast cells; Vitamin D

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; CALCIMYCIN; CALCITRIOL; CYTOCHALASIN D; IMMUNOGLOBULIN E; PHORBOL ESTER; VITAMIN D RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEGRANULATION; EXOCYTOSIS; IMMUNOBLOTTING; MAST CELL; MAST CELL LEUKEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIGENS; BETA-N-ACETYLHEXOSAMINIDASE; CALCIMYCIN; CALCITRIOL; CELL DEGRANULATION; CYTOCHALASIN D; DINITROPHENOLS; EXOCYTOSIS; IMMUNOGLOBULIN E; LEUKEMIA, BASOPHILIC, ACUTE; MAST CELLS; MICE; NUCLEIC ACID SYNTHESIS INHIBITORS; RATS; RECEPTORS, CALCITRIOL; TUMOR CELLS, CULTURED;

EID: 0032566144     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(98)00119-1     Document Type: Article

References (37)

1. 3. J. Cell. Biochem. 56:1994;303-306.
2. Beaven M.A., Metzger H. Signal transduction by Fc receptors: the FcεRI case. Immunol. Today. 14:1993;222-225.
3. Bjermer L., Engstrom-Laurent A., Thunell M., Hallgren R. The mast cell and signs of pulmonary fibroblast activation in sarcoidosis. Int. Arch. Allergy Immunol. 82:1987;298-301.
4. 3. Curr. Opin. Nephrol. Hypertens. 4:1995;313-318.
5. Claman, H.N., 1993. Mast cells and fibrosis: hints from graft-versus-host disease and sclerodrma. In: Kaliner, M.A., Metcalfe, D.D. (Eds.), The mast cell in health and disease. Dekker, N.Y., pp. 653-667.
6. De-Boland A.R., Boland R.L. Non-genomic signal transduction pathway of vitamin D in muscle. Cell Signal. 6:1994;717-724.
7. Dusso A., Finch J., Delmez J., Rapp N., Lopez-Hilker S., Brown A., Slatopolsky E. Extrarenal production of calcitriol. Kidney Int. 29:1990;S36-S40.
8. 3 enhances thyrotropin releasing hormone-induced thyrotropin secretion in normal pituitary cells. Endocrinology. 121:1987;1192-1194.
9. Finter N.B. Quantitative hemadsorption, a new assay technique. II. assay of neutralizing antibodies to hemadsorbing viruses. J. Immunol. 98:1967;88-93.
10. Foreman J.C., Garland L.G. Desensitization in the process of histamine secretion induced by antigen and dextran. J. Physiol. 239:1974;381-391.
11. Galli S.J. New concepts about the mast cell. New Engl. J. Med. 328:1993;257-265.
12. Gomperts B.D., Churcher Y., Koffer A., Lillie T.H.W., Tatham P.E.R., Whalley T.D. Intracellular mechanisms regulating exocytosic secretion im mast cells. Int. Arch. Allergy Appl. Immunol. 94:1991;38-46.
13. Gomperts B.D., Tatham P.E. Regulated exocytotic secretion from permeabilized cells. Methods Enzymol. 219:1992;178-189.
14. Gruber B., Poznansky M., Boss E., Partin J., Gorevic P., Kaplan A. Characterization and functional studies of rheumatoid synovial mast cells. Arthritis Rheum. 29:1986;944-955.
15. 3, by synovial fluid macrophages in arthritic diseases. Ann. Rheum. Dis. 48:1989;723-729.
16. 2+ at concentrations buffered in the micromlar range. Biochim. Biophys. acta. 927:1987;177-183.
17. 3, J. Cell. Biochem. 49:1992;26-31.
18. 3. J. Steroid Biochem. Mol. Biol. 53:1995;599-602.
19. Lomri A., Marie P.J. Changes in cytoskeletal proteins in response to parathyroid hormone and 1,25-dihydroxyvitamin D in human osteoblastic cells. Bone Miner. 10:1990;1-12.
20. 3 and the immune system. Proc. Soc. Exp. Biol. Med. 191:1989;238-245.
21. Mawer E.B., Hayes M.E., Still P.E. et al. Evidence for nonrenal synthesis of 1,25-dihydroxyvitamin D in patients with inflammatory arthritis. J. Bone Miner. Res. 6:1991;733-739.
22. Minamide L.S., Bamburg J.R. A filter paper dye-binding assay for quantitative determination of protein without interference from reducing agents or detergents. Anal. Biochem. 190:1990;66-70.
23. Narasimhan V., Holowka D., Baird B. Microfilaments regulate the rate of exocytosis in rat basophilic leukemia cells. Biochem. Biophys. Res. Commun. 171:1990;222-229.
24. 3 in HL-60 cells. J. Biol. Chem. 265:1990;2370-2374.
25. 3 increases cytotoxicity and exocytosis in lymphokine-activated killer cells. Mol. Cell. Endocrinol. 96:1993;133-139.
26. Schwartz L., Huff T. Biology of mast cells and basophils. Middleton E. Jr., Reed C.E., Ellis E.F., Adkinson Jr N.F., Yunginger J.W., Busse W.W. Allergy, Principles and Practice. 4th ed. 1993;135-168 Mosby-Year Book, St. Louis.
27. Seldin D.C., Adelman S., Austen K.F. et al. Homology of the rat basophilic leukemia cell and the rat mucosal mast cell. Proc. Natl. Acad. Sci. USA. 82:1985;3871-3875.
28. Serup J., Hagdrup H.K. Increased 1.25-dihydroxyvitamin D in patients with generalized scleroderma and no aberrant calcifications. Arch. Dermatol. Res. 276:1984;205-206.
29. 3. J. Biol. Chem. 270:1995;6639-6643.
30. Sontag J.M., Aunis D., Bader M.F. Peripheral actin filaments control calcium-mediated catecholamine release from streptolysin-O-permeabilized chromaffin cells. Eur. J. Cell Biol. 46:1988;316-326.
31. 2+ exchange. Endocrinology. 124:1989;2765-2776.
32. Walters M.R. Newly identified actions of the vitamin D endocrine system. Endocr. Rev. 13:1992;719-764.
33. 1) cells. J. Endocrinol. 117:1988;293-298.
34. 3, and retinoid signalling. Endocrinology. 135:1994;2375-2385.
35. 3 increases the sensitivity of human renal carcinoma cells to tumor necrosis factor α but not to interferon α or lymphokine-activated-killer cells. J. Endocrinol. 149:1996;327-333.
36. Young J.D.E., Liu C.C., Butler G., Cohn Z.A., Galli S.J. Identification, purification, and characterization of a mast cell-associated cytolytic factor related to tumor necrosis factor. Proc. Natl. Acad. Sci. USA. 84:1987;9175-9179.
37. 3 coupled to a decline in protein kinase A activity and an increase in cytoskeletal organization. Clin. Exp. Metastasis. 15:1997;102-110.